Eva Meixner

492 total citations
41 papers, 236 citations indexed

About

Eva Meixner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Eva Meixner has authored 41 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 11 papers in Oncology. Recurrent topics in Eva Meixner's work include Endometrial and Cervical Cancer Treatments (11 papers), Brain Metastases and Treatment (9 papers) and Glioma Diagnosis and Treatment (8 papers). Eva Meixner is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Brain Metastases and Treatment (9 papers) and Glioma Diagnosis and Treatment (8 papers). Eva Meixner collaborates with scholars based in Germany, United States and Italy. Eva Meixner's co-authors include Georg Michelson, Jürgen Debus, Juliane Hörner‐Rieber, Laila König, Philipp Hoegen, Jonathan W. Lischalk, Kristin Lang, Semi Harrabi, Wolf Schweitzer and Nathalie Arians and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and Cancers.

In The Last Decade

Eva Meixner

37 papers receiving 232 citations

Peers

Eva Meixner
Omar Ragab United States
Eva Meixner
Citations per year, relative to Eva Meixner Eva Meixner (= 1×) peers Omar Ragab

Countries citing papers authored by Eva Meixner

Since Specialization
Citations

This map shows the geographic impact of Eva Meixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Meixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Meixner more than expected).

Fields of papers citing papers by Eva Meixner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Meixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Meixner. The network helps show where Eva Meixner may publish in the future.

Co-authorship network of co-authors of Eva Meixner

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Meixner. A scholar is included among the top collaborators of Eva Meixner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Meixner. Eva Meixner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Harold, Fabian Weykamp, Sebastian Regnery, et al.. (2025). Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?. Clinical and Translational Radiation Oncology. 52. 100941–100941.
2.
Lehner, Burkhard, Eva Meixner, Laila König, et al.. (2025). Recurrence Patterns After Resection of Sacral Chordoma: Toward an Optimized Postoperative Target Volume Definition. Cancers. 17(15). 2521–2521.
3.
Gupta, Anil, Eva Meixner, Laila König, et al.. (2024). Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies. Technology in Cancer Research & Treatment. 23. 2233994510–2233994510. 3 indexed citations
4.
Weykamp, Fabian, Eva Meixner, Nathalie Arians, et al.. (2024). Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy for Cervical Cancer 1: The AIM-C1 Trial. Journal of Clinical Medicine. 13(4). 957–957. 2 indexed citations
5.
Thomas, Michael, Petros Christopoulos, Jonathan W. Lischalk, et al.. (2024). Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors. Clinical and Translational Radiation Oncology. 50. 100893–100893.
6.
Jungk, Christine, Michael Thomas, Petros Christopoulos, et al.. (2024). Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors. Clinical and Translational Radiation Oncology. 46. 100782–100782. 2 indexed citations
7.
Meixner, Eva, Sebastian Klüter, Semi Harrabi, et al.. (2024). Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation. Clinical and Translational Radiation Oncology. 49. 100855–100855. 1 indexed citations
8.
Krug, David, Joke Tio, Khaled Elsayad, et al.. (2024). The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study. Cancers. 16(9). 1649–1649. 5 indexed citations
9.
Meixner, Eva, Philipp Hoegen, Fabian Weykamp, et al.. (2023). Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer. Technology in Cancer Research & Treatment. 22. 2223906425–2223906425. 5 indexed citations
12.
Tessonnier, Thomas, Eva Meixner, Philipp Hoegen, et al.. (2023). Proton Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma. Cancers. 15(20). 5022–5022. 3 indexed citations
13.
Eichkorn, Tanja, Jonathan W. Lischalk, Juliane Hörner‐Rieber, et al.. (2023). Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3. Journal of Neuro-Oncology. 162(3). 489–501. 8 indexed citations
14.
Meixner, Eva, Juliane Hörner‐Rieber, Jonathan W. Lischalk, et al.. (2023). Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids. Clinical and Translational Radiation Oncology. 39. 100600–100600. 7 indexed citations
15.
Arians, Nathalie, Katja Lindel, Johannes Krisam, et al.. (2023). Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial. International Journal of Radiation Oncology*Biology*Physics. 116(4). 825–836. 4 indexed citations
16.
Weykamp, Fabian, Philipp Hoegen, Sebastian Regnery, et al.. (2023). Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases. Cancers. 15(10). 2786–2786. 10 indexed citations
17.
Hoegen, Philipp, Sebastian Regnery, Fabian Weykamp, et al.. (2022). Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk. Clinical and Translational Radiation Oncology. 39. 100567–100567. 11 indexed citations
18.
Eichkorn, Tanja, Jonathan W. Lischalk, Eva Meixner, et al.. (2022). Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1–3 following photon and proton radiotherapy. Radiotherapy and Oncology. 175. 133–143. 8 indexed citations
19.
Eichkorn, Tanja, Julia Bauer, Emanuel Bahn, et al.. (2022). Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults. Radiotherapy and Oncology. 172. 54–64. 11 indexed citations
20.
Meixner, Eva & Georg Michelson. (2015). Measurement of retinal wall-to-lumen ratio by adaptive optics retinal camera: a clinical research. Graefe s Archive for Clinical and Experimental Ophthalmology. 253(11). 1985–1995. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026